Biomarkers of necrotisingenterocolitis

Author(s): Ng PC


Different categories of biomarkers of necrotising enterocolitis (NEC), including (i) non-specific mediators of the inflammatory cascade, e.g. acute phase reactants, chemokines, cytokines, and cell surface antigens, (ii) enhanced non-specific biomarkers, and (iii) specific gut-associated proteins, have distinctive biochemical characteristics and properties. The appropriateness of using these mediators in specific clinical situations, and the pros and cons of their applications as indicators or predictors of intestinal injury and NEC are highlighted. Many potentially new biomarkers such as micro-RNA, volatile organic compounds and gut microbiomes are currently under investigation. A stringent protocol for biomarker discovery is revealed so that investigators can consider this methodology as a reference for future discovery of organ-specific and/or disease-specific biomarkers for preterm infants.

Similar Articles

Neonatal necrotizing enterocolitis: Therapeutic decisions based upon clinical staging

Author(s): Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, et al.

The early use of minimal enteral nutrition in extremely low birth weight newborns

Author(s): Mosqueda E, Sapiegiene L, Glynn L, Wilson-Costello D, Weiss M

Necrotizing enterocolitis in 20,822 infants: analysis of medical and surgical treatments

Author(s): Abdullah F, Zhang Y, Camp M, Mukherjee D, Gabre-Kidan A, et al.

Survival and morbidity of infants with necrotizing enterocolitis treated with surgery

Author(s): García H, Franco-Gutiérrez M, Gutiérrez-Hernández JI

Short-term outcomes for preterm infants with surgical necrotizing enterocolitis

Author(s): Murthy K, Yanowitz TD, DiGeronimo R, Dykes FD, Zaniletti I, et al.

Mortality and intestinal failure in surgical necrotizing enterocolitis

Author(s): Kelleher J, Mallick H, Soltau TD, Harmon CM, Dimmitt RA